According to MedImmune, the AstraZeneca subsidiary that makes FluMist, studies have shown that people ages 18 to 49 can successfully give the vaccine, and it's just as effective as having a doctor ...
MTS Health Partners ("MTS") announced today that healthcare investment banker Aaron Schwimmer has joined their global life sciences practice as a Partner based in New York.